Get notified of page updates
Risk Management and Treatment by Mutation
Read about different genes that are linked to hereditary cancer, their associated risks and guidelines for screening, preventing and treating cancers in people with inherited mutations in these genes.

Stay up to date on research and information

Sign Up for FORCE Newsletters

Hereditary Cancer and Genetic Testing > Hereditary Cancer Genes and Risk > Risk Management and Treatment by Mutation

Risk Management and Treatment by Mutation Genes by Cancer Types Genes by Syndrome
Glossary on
off

Cancer Risk, Screening, Prevention and Treatment for People with Inherited Mutations

Mutations in these genes have been linked to increased risk for different types of cancer. Learn more about the risks, expert guidelines, resources and research for each gene. If you have an in a gene not listed here, please contact us for information and resources. 

APC ATM BARD1 BRCA1 BRCA2 BRIP1 CDH1 CDKN2A CDK4 CHEK2 EPCAM (Lynch syndrome) HOXB13 MLH1 (Lynch syndrome) MSH2 (Lynch syndrome) MSH6 (Lynch syndrome) MUTYH NBN PALB2 PMS2 (Lynch syndrome) PTEN (Cowden syndrome) RAD51C RAD51D STK11 (Peutz-Jeghers syndrome) TP53 (Li-Fraumeni syndrome)
Last updated June 11, 2023